Eltrombopag API Manufacturers & Suppliers

Looking for Eltrombopag API 496775-61-2?

Description:

Here you will find a list of producers, manufacturers and distributors of Eltrombopag. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Eltrombopag 

Synonyms:

Eltrombopagum , Eltrombopag , Promacta  

Cas Number:

496775-61-2 

DrugBank number:

DB06210 

Unique Ingredient Identifier:

S56D65XJ9G

Eltrombopag is a type of Other antithrombin

The Other Antithrombin subcategory in pharmaceutical active pharmaceutical ingredients (APIs) refers to a class of compounds that exhibit antithrombin activity but do not fall under the traditional anticoagulant or antiplatelet categories. These APIs play a crucial role in preventing blood clot formation and reducing the risk of thrombotic events.

One notable API in this subcategory is [Name of the API], which demonstrates potent antithrombin properties by inhibiting specific clotting factors in the blood. By targeting these factors, [Name of the API] helps regulate the coagulation cascade, a complex process involved in blood clot formation.

The unique mechanism of action of [Name of the API] distinguishes it from other antithrombin APIs, making it a valuable option for treating thrombotic disorders. This API exhibits high selectivity, effectively inhibiting clotting factors without significantly impacting other blood components or processes.

[Name of the API] is carefully developed and rigorously tested to ensure its safety, efficacy, and reliability. It undergoes stringent quality control measures to meet regulatory standards and ensure consistency in its performance.

Pharmaceutical companies incorporate [Name of the API] into various formulations, such as oral tablets, injections, or topical preparations, enabling healthcare providers to administer it in the most suitable form for patients.

The Other Antithrombin subcategory in pharmaceutical APIs, with [Name of the API] as a prominent member, provides an innovative therapeutic approach to managing thrombotic disorders and contributes to enhancing patient care and outcomes in the field of hematology.

Eltrombopag (Other antithrombin), classified under Anticoagulants

Anticoagulants are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to prevent and treat blood clotting disorders. These medications play a crucial role in various medical conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). Anticoagulants work by inhibiting the formation of blood clots or by preventing existing clots from getting larger.

There are different types of anticoagulants available, including direct thrombin inhibitors, vitamin K antagonists, and factor Xa inhibitors. Direct thrombin inhibitors, such as dabigatran, directly target the enzyme thrombin to hinder clot formation. Vitamin K antagonists, like warfarin, interfere with the production of clotting factors that rely on vitamin K. Factor Xa inhibitors, such as rivaroxaban and apixaban, inhibit the activity of factor Xa, a crucial component in the clotting cascade.

Anticoagulants are commonly prescribed to patients at risk of developing blood clots or those with existing clotting disorders. They are often used during surgeries, such as hip or knee replacements, to minimize the risk of post-operative clot formation. Patients with AF, a condition characterized by irregular heart rhythm, may also be prescribed anticoagulants to prevent stroke caused by blood clots.

While anticoagulants offer significant benefits in preventing and treating clot-related conditions, they also carry potential risks, including bleeding complications. Patients taking anticoagulants require careful monitoring to ensure the right dosage is administered, as excessive anticoagulation can lead to hemorrhage. Regular blood tests and close medical supervision are essential to manage the delicate balance between preventing clots and avoiding excessive bleeding.

In conclusion, anticoagulants are a crucial category of pharmaceutical APIs used to prevent and treat blood clotting disorders. They function by inhibiting clot formation or preventing existing clots from enlarging. While highly beneficial, their use requires careful monitoring to minimize the risk of bleeding complications.

• Shilpa Medicare Ltd from India, product country of origin India
• Sinoway industrial Co.,Ltd from China, product country of origin China
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Saneca Pharma from Slovakia, product country of origin Slovakia
• Raks Pharma from India, product country of origin India
• ACE Japan from Japan, product country of origin Japan
• MSN Labs. from India, product country of origin India
• Hetero Drugs from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.